50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,640.07 (-2.12%)
DOW   29,217.47 (-1.57%)
QQQ   271.84 (-2.89%)
AAPL   142.76 (-4.73%)
MSFT   235.90 (-2.14%)
META   137.68 (-2.78%)
GOOGL   96.57 (-3.48%)
AMZN   114.92 (-2.62%)
TSLA   270.73 (-5.93%)
NVDA   121.34 (-4.73%)
NIO   15.63 (-9.81%)
BABA   78.46 (-3.12%)
AMD   64.09 (-6.25%)
T   15.52 (-1.96%)
MU   49.99 (-1.98%)
CGC   2.83 (-6.91%)
F   11.54 (-5.25%)
GE   62.54 (-2.98%)
DIS   97.53 (-1.88%)
AMC   7.22 (-5.87%)
PYPL   89.57 (-1.70%)
PFE   44.42 (-0.02%)
NFLX   241.43 (-1.54%)
S&P 500   3,640.07 (-2.12%)
DOW   29,217.47 (-1.57%)
QQQ   271.84 (-2.89%)
AAPL   142.76 (-4.73%)
MSFT   235.90 (-2.14%)
META   137.68 (-2.78%)
GOOGL   96.57 (-3.48%)
AMZN   114.92 (-2.62%)
TSLA   270.73 (-5.93%)
NVDA   121.34 (-4.73%)
NIO   15.63 (-9.81%)
BABA   78.46 (-3.12%)
AMD   64.09 (-6.25%)
T   15.52 (-1.96%)
MU   49.99 (-1.98%)
CGC   2.83 (-6.91%)
F   11.54 (-5.25%)
GE   62.54 (-2.98%)
DIS   97.53 (-1.88%)
AMC   7.22 (-5.87%)
PYPL   89.57 (-1.70%)
PFE   44.42 (-0.02%)
NFLX   241.43 (-1.54%)
S&P 500   3,640.07 (-2.12%)
DOW   29,217.47 (-1.57%)
QQQ   271.84 (-2.89%)
AAPL   142.76 (-4.73%)
MSFT   235.90 (-2.14%)
META   137.68 (-2.78%)
GOOGL   96.57 (-3.48%)
AMZN   114.92 (-2.62%)
TSLA   270.73 (-5.93%)
NVDA   121.34 (-4.73%)
NIO   15.63 (-9.81%)
BABA   78.46 (-3.12%)
AMD   64.09 (-6.25%)
T   15.52 (-1.96%)
MU   49.99 (-1.98%)
CGC   2.83 (-6.91%)
F   11.54 (-5.25%)
GE   62.54 (-2.98%)
DIS   97.53 (-1.88%)
AMC   7.22 (-5.87%)
PYPL   89.57 (-1.70%)
PFE   44.42 (-0.02%)
NFLX   241.43 (-1.54%)
S&P 500   3,640.07 (-2.12%)
DOW   29,217.47 (-1.57%)
QQQ   271.84 (-2.89%)
AAPL   142.76 (-4.73%)
MSFT   235.90 (-2.14%)
META   137.68 (-2.78%)
GOOGL   96.57 (-3.48%)
AMZN   114.92 (-2.62%)
TSLA   270.73 (-5.93%)
NVDA   121.34 (-4.73%)
NIO   15.63 (-9.81%)
BABA   78.46 (-3.12%)
AMD   64.09 (-6.25%)
T   15.52 (-1.96%)
MU   49.99 (-1.98%)
CGC   2.83 (-6.91%)
F   11.54 (-5.25%)
GE   62.54 (-2.98%)
DIS   97.53 (-1.88%)
AMC   7.22 (-5.87%)
PYPL   89.57 (-1.70%)
PFE   44.42 (-0.02%)
NFLX   241.43 (-1.54%)
CVE:BTI

Bioasis Technologies - BTI Stock Forecast, Price & News

C$0.15
-0.02 (-11.76%)
(As of 09/28/2022 05:21 PM ET)
Add
Compare
Today's Range
C$0.15
C$0.15
50-Day Range
C$0.13
C$0.24
52-Week Range
C$0.12
C$0.32
Volume
1,500 shs
Average Volume
28,792 shs
Market Capitalization
C$11.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Bioasis Technologies

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited to focus on the delivery of siRNA therapeutics for CNS disorders; Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane's OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain; and Janssen Biotech, Inc. to research, develop, and commercialize novel products based on Bioasis' xB3 platform. The company also has a research collaboration and license agreement with Neuramedy Co Ltd. to research, develop, and commercialize an xB3TM version of its antibody, Tomaralimab. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut.

Receive BTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioasis Technologies and its competitors with MarketBeat's FREE daily newsletter.

BTI Stock News Headlines

BIOAF: FY 2022 Results and Valuation Update
Bioasis to Attend Upcoming Industry Conferences
biOasis Technologies Inc.
Bioasis Technologies Inc. (BTI.V)
NA Proactive news snapshot: Arizona Silver Exploration,...
IIROC Trading Resumption - BTI
IIROC Trading Halt - BTI
Cortexyme Inc.
Bioasis Announces FDA Response to Pre-IND Submission
Bioasis Announces Private Placement
See More Headlines
Receive BTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioasis Technologies and its competitors with MarketBeat's FREE daily newsletter.

BTI Company Calendar

Today
9/29/2022
Next Earnings (Estimated)
10/27/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
55,329
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$37,725.00
Cash Flow
C$0.01 per share
Book Value
C($0.03) per share

Miscellaneous

Free Float
N/A
Market Cap
C$11.91 million
Optionable
Optionable
Beta
N/A

Key Executives

  • Dr. Deborah Ann Rathjen B.Sc. (Hons.) (Age 64)
    FTSE, M.A.I.C.D., Ph.D., Q.C., Exec. Chairman, CEO & Pres
    Comp: $190.28k
  • Mr. Dave Jenkins
    Chief Financial Officer
  • Mr. Graeme Dick
    Director of Investor Relations
  • Mr. Kim Elton
    Director of Marketing
  • Mr. Doug Williams MBA
    Exec. VP & Chief Bus. Officer
  • Dr. Mei Mei Tian
    VP & Head of External Research













BTI Stock - Frequently Asked Questions

How have BTI shares performed in 2022?

Bioasis Technologies' stock was trading at C$0.27 on January 1st, 2022. Since then, BTI stock has decreased by 44.4% and is now trading at C$0.15.
View the best growth stocks for 2022 here
.

When is Bioasis Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our BTI earnings forecast
.

Is Bioasis Technologies a good dividend stock?

Bioasis Technologies (CVE:BTI) pays an annual dividend of C$2.02 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Bioasis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioasis Technologies investors own include Praxair (PX), OrganiGram (OGI), Morningstar (MORN), Five Below (FIVE), Extendicare (EXE), Trees (CANN), Blackstone Mortgage Trust (BXMT) and Bank of America (BAC).

What is Bioasis Technologies' stock symbol?

Bioasis Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "BTI."

How do I buy shares of Bioasis Technologies?

Shares of BTI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Bioasis Technologies' stock price today?

One share of BTI stock can currently be purchased for approximately C$0.15.

How much money does Bioasis Technologies make?

Bioasis Technologies (CVE:BTI) has a market capitalization of C$11.91 million and generates C$37,725.00 in revenue each year.

How many employees does Bioasis Technologies have?

The company employs 55,329 workers across the globe.

How can I contact Bioasis Technologies?

Bioasis Technologies' mailing address is 130-10691 Shellbridge Way, RICHMOND, BC V6X 2W8, Canada. The official website for the company is www.bioasis.ca. The company can be reached via phone at +1-604-2957014.

This page (CVE:BTI) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.